Notes / Company

Gujarat Themis Biosyn Ltd.

GUJTHEM BSE 506879 ISIN INE942C01045 Pharmaceuticals

Fundamentals

Market cap: ₹3,971 cr
P/E: 83.11×
ROE: 19.64%
Debt / equity: 0.12
Div yield: 0.18%
52-week range: 225.75 — 479.45

Research on Tijori Finance

The timeline — 1 note on Gujarat Themis Biosyn Ltd.

May 2026

22 May 26 · 20:39 IST Alert

Alert · M&A

Gujarat Themis Biosyn bets ₹1,300 cr to buy Japan's MicroBiopharm

The deal is valued at 33% of the company's market cap and aims to shift its focus from intermediates to high-tech CDMO services.

Verify on exchange BSE filings for GUJTHEM NSE filings for GUJTHEM Tijori Finance company page